ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ZNTL Zentalis Pharmaceuticals Inc

12.54
0.02 (0.16%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Zentalis Pharmaceuticals Inc ZNTL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 0.16% 12.54 06:15:09
Open Price Low Price High Price Close Price Previous Close
12.49 11.78 12.74 12.54 12.52
more quote information »

Recent News

Date Time Source Heading
07/5/202421:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202421:03EDGAR2Form 8-K - Current report
07/5/202421:00GLOBEZentalis Pharmaceuticals Reports First Quarter 2024..
02/5/202407:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
03/4/202407:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
02/4/202408:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02/3/202410:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
01/3/202409:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202409:14EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202423:00GLOBEZentalis Pharmaceuticals to Participate in Upcoming Investor..
27/2/202423:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202423:04EDGAR2Form 8-K - Current report
27/2/202423:00GLOBEZentalis Pharmaceuticals Reports Full Year 2023 Financial..
16/2/202408:12EDGAR2Form 8-K - Current report
14/2/202411:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:00GLOBEZentalis Pharmaceuticals to Participate in the Oppenheimer..
13/2/202412:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202412:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202412:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202413:29EDGAR2Form 144 - Report of proposed sale of securities
03/2/202413:29EDGAR2Form 144 - Report of proposed sale of securities
03/2/202413:28EDGAR2Form 144 - Report of proposed sale of securities
03/2/202413:27EDGAR2Form 144 - Report of proposed sale of securities
03/2/202413:26EDGAR2Form 144 - Report of proposed sale of securities
02/2/202409:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
25/1/202423:03EDGAR2Form 8-K - Current report
25/1/202423:00GLOBEZentalis Pharmaceuticals Strengthens Management Team with..
08/1/202423:03EDGAR2Form 8-K - Current report
08/1/202423:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04/1/202412:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202412:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:49GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
22/12/202309:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202309:39GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
14/11/202309:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202323:00GLOBEZentalis to Participate in Investor Call Focused on Ovarian..
07/11/202301:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202301:04EDGAR2Form 8-K - Current report
06/11/202323:18GLOBEZentalis Pharmaceuticals Reports Third Quarter 2023..
02/11/202307:52GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
07/10/202310:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202310:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202310:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:00EDGAR2Form 8-K - Current report
05/10/202311:28EDGAR2Form 144 - Report of proposed sale of securities